1Palmer AJ,Ho CKM,Ajibola O,et al. The role of to-3 fatty acid supplemented parenteral nutrition in critical illness in adults: a systematic review and meta-analysis [J]. Critical Care Medi cine ,2013,41 ( 1 ) :307-316.
2Sungurtekin H, Deirmenci S, Sungurtekin U, et al. Comparison of the effects of different intravenous fat emulsions in patients with systemic inflammatory response syndrome and sepsis [J]. Nutrition in Clinical Practice, 2011,26 (6) : 665-671.
3Manzanares W,Dhaliwal R,Jurewitsch B,et al. Alternative lipid emulsions in the critically ill:a systematic review of the evidence [J]. Intensive Care Medicine,2013,39( 10):1-12.
4Hagi A, Nakayama M, Shinzaki W, et al. Effects of the ω-6: ω-3 fatty acid ratio of fat emulsions on the fatty acid compo- sition in cell membranes and the anti-inflammatory action [J]. Journal of Parenteral and Enteral Nutrition,2010,34 (3): 263 -270.
5Rice TW,Wheeler AP,Thompson BT,et al. Enteral omega-3 fatty acid, γ-linolenie acid, and antioxidant supplementation in acute lun$ injury [J]. JAMA-Journal of the American Med- ical Association, 2011,306 (14) : 1574.
6Wall R, Ross RP, Fitzgerald GF, et al. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids [J]. Nutrition Reviews, 2010,68 (5) :280-289.
7GALBN C,MONTEJO J C,MESEJO A,et al. An immune-en- hancing enteral diet reduces mortality rate and episodes of bac- teremia in septic intensive care unit patients [J]. Crit Care Med, 2000,28(3):643-648.
8WANTEN G J, CALDER P C. Immune modulation by parenter- al lipid emulsions [J]. Am J Clin Nutr,2007,85 (5):1171- 1184.
9DECKELBAUM R J,WORGALL T S,SEO T. n-3 fatty acids and gene expression[J]. Am J Clin Nutr,2006,83(6 Suppl) : 1520S- 1525S.
10WISCHMEYER P E. Glutamine : mode of action in critical ill- ness[J]. Grit Care Med,2007,35(9) :S541-S544.
